Reliable GLP-1 Aggregate Analysis Using Biozen dSEC-1
As peptide-based therapeutics continue to expand, understanding and controlling aggregation behavior has become essential for ensuring drug safety and efficacy. This webinar provides a focused exploration of peptide aggregation mechanisms and how Size Exclusion Chromatography (SEC) can be applied to characterize these critical quality attributes. Attendees will be introduced to the separation principles behind SEC and learn how Biozen dSEC‑1 can improve peptide aggregate detection and quantification. Real-world applications will cover aggregation profiles of key GLP‑1 receptor agonists including semaglutide, liraglutide, and tirzepatide.